Company intelligence / Profile preview

Neopharm

Petah Tikva, Central, Israelneopharmlabs.com ↗

Ownership: Public · 092730
Employees: ~1000
Development stage: Commercial

Overview

Neopharm is one of Israel’s leading pharmaceutical companies and healthcare solution providers. It offers integrated services including R&D support, manufacturing, marketing, sales, distribution and analytical testing. The company acts as a key partner-of-choice for multinational pharma/biotech firms seeking market access in Israel. It also provides GMP analytical services through its labs division. Clinical results are not directly reported since it does not develop proprietary drugs but rather partners with or represents global brands in the region.

Therapeutic areas: Other
Modalities: Small moleculeBiologicVaccine
Industry: Contract Manufacturing Organization

Partnerships

Major partnerships with multinational pharmaceutical companies seeking entry or expansion in Israel; historical relationships include Lederle Labs/Pfizer/Wyeth/Organon/Park-Davis/Hermal-Almirall among others.

Beyond the preview

Go deeper on Neopharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neopharm.

Explore the full profile